Olivia C. Ware

Insider Reports History

Location
11726 San Vicente Blvd, Suite 650, Los Angeles, CA
Signature
/s/ Peter Slover, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Olivia C. Ware:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Revance Therapeutics, Inc. Director Common Stock 0 $0 $3.65 Feb 6, 2025 Direct
Revance Therapeutics, Inc. Director Stock Option (Right to buy) 23.5K May 1, 2024 Direct
Contineum Therapeutics, Inc. Director Stock Option (right to buy) 14.8K Jun 26, 2025 Direct
Arcellx, Inc. Director Stock Option (right to buy) 9.17K May 29, 2025 Direct

Insider Reports Filed by Olivia C. Ware

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CTNM Contineum Therapeutics, Inc. Jun 26, 2025 1 $0 4 Jun 26, 2025 Director
ACLX Arcellx, Inc. May 29, 2025 1 $0 4 May 30, 2025 Director
RVNC Revance Therapeutics, Inc. Feb 4, 2025 2 -$60.9K 4 Feb 6, 2025 Director
ACLX Arcellx, Inc. May 28, 2024 1 $0 4 Jun 6, 2024 Director
CTNM Contineum Therapeutics, Inc. May 24, 2024 1 $0 4 May 29, 2024 Director
RVNC Revance Therapeutics, Inc. May 1, 2024 2 $0 4 May 3, 2024 Director
ACLX Arcellx, Inc. Apr 16, 2024 4 -$451K 4 Apr 18, 2024 Director
CTNM Contineum Therapeutics, Inc. Apr 4, 2024 0 $0 3 Apr 4, 2024 Director
ACLX Arcellx, Inc. Mar 15, 2024 5 -$565K 4 Mar 18, 2024 Director
ACLX Arcellx, Inc. Jun 14, 2023 1 $0 4 Jun 16, 2023 Director
RVNC Revance Therapeutics, Inc. May 3, 2023 2 $0 4 May 5, 2023 Director
ACLX Arcellx, Inc. May 16, 2022 1 $0 4 May 17, 2022 Director
ACLX Arcellx, Inc. May 16, 2022 0 $0 3 May 17, 2022 Director
RVNC Revance Therapeutics, Inc. May 4, 2022 1 $0 4/A May 13, 2022 Director
RVNC Revance Therapeutics, Inc. May 5, 2021 2 $0 4 May 7, 2021 Director